Ocugen Inc
OCGN
NASDAQ
Biotechnology
$1.35
USD
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $457.80M
Volume 3.0M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SCTX | Scribe Therapeutics Inc | - | - | - | - | |
OCGN | Ocugen Inc | $457.80M | - | +0.4% | - | |
PBYI | Puma Biotechnology Inc | $454.88M | 18.65 | -2.4% | - | |
RZLT | Rezolute Inc | $450.65M | - | - | - | |
EDIT | Editas Medicine Inc | $441.54M | - | +20.8% | - | |
FENC | Fennec Pharmaceuticals Inc | $420.32M | - | +33.8% | - | |
LRMR | Larimar Therapeutics Inc | $416.57M | - | - | - | |
CCCC | C4 Therapeutics, Inc | $400.25M | - | -12.4% | - | |
ABEO | Abeona Therapeutics Inc | $363.91M | 5.50 | - | - | |
STRO | Sutro Biopharma Inc | $360.08M | - | +49.9% | - |
Top Peer by Growth
Ovid Therapeutics Inc
+1199.6% YoY Revenue
Lowest P/E Ratio
Q32 Bio Inc
15.71x P/E
Best 1-Year Return
Q32 Bio Inc
+749.2% Return